Infervision
This page has not yet been verified by the manufacturer.
View Website

InferRead DR Chest

Assist in tuburculosis and lung nodule detection and analysis

Product Overview

Intended Use

TB and lung nodule detection and analysis

Input Data

X-ray images

Output Data

Browser-based viewer or integration into PACS/RIS

Public information

Efficacy

Retrospective cohort study (OCEBM 3) testing DL model for identifying fresh vertebral compression fractures (VCFs) with MRI as reference standard. 1877 VCFs in 1099 patients; 824 for training and 275 for testing.

The ensemble model identified fresh and old VCFs, reaching an AUC of 0.80 (95% confidence interval [CI], 0.77–0.83), an accuracy of 74% (95% CI, 72–77%), a sensitivity of 80% (95% CI, 77–83%), and a specificity of 68% (95% CI, 63–72%). Lateral (AUC, 0.83) views exhibited better performance than anteroposterior views (AUC, 0.77)Comparison of 5 DL models, including InferRead DR, against 3 radiologists and WHO's Target Product Profile (TPP) triage of tests (>90sens and >70% spec) in detecting TB in patients in Bangladesh. 23,954 CXRs included.

All five AI algorithms significantly outperformed the radiologists. The areas under the receiver operating characteristic curve were 90·81% (95% CI 90·33–91·29) for qXR, 90·34% (89·81–90·87) for CAD4TB, 88·61% (88·03–89·20) for Lunit INSIGHT CXR, 84·90% (84·27–85·54) for InferRead DR, and 84·89% (84·26–85·53) for JF CXR-1. Only qXR (74·3% specificity [95% CI 73·3–74·9]) and CAD4TB (72·9% specificity [72·3–73·5]) met the TPP at 90% sensitivity. All five AI algorithms reduced the number of Xpert tests required by 50% while maintaining a sensitivity above 90%. All AI algorithms performed worse among older age groups (>60 years) and people with a history of tuberculosis

RWE

InferRead® DR Chest out-performed expert local radiologists when detecting TB in Bangladesh.

  • AUC= 84.90% (84.27-85.54)
  • Halved the number of diagnostic tests required, retaining sensitivity >90%
Related Function
Image analysis - Xray
Related Domain
Radiology
Market Approval